2026 Agenda Topics:

Investment, Capital & Company Growth:

• Investing in Medtech Now: Where Capital Is Moving—and Why
• From Startup to Scale: Navigating the Path to Mid-Stage and Beyond
• Capital Strategy, Risk Tolerance, and Proof Points Investors Demand
• Valuation, Timing, and Fundraising Readiness in a Selective Market

M&A, Partnerships & Strategic Growth:

• How Medtech Incumbents Scale Innovation Through M&A and Partnerships
• Build vs. Buy vs. Partner: Strategic Decision-Making Inside Large Operators
• What Makes an Asset “Must-Buy” vs. a Long-Term Partnership
• Timing, Integration Risk, and Acquisition Readiness for Founders

Technology, AI & Robotics:

• Tech Inside Medtech: How AI Platforms Are Powering the Next Generation of Devices
• AI-Enabled Devices: Infrastructure, Validation, and Real-World Deployment
• Robotics Across Care Settings: From the OR to Enterprise-Wide Adoption
• Automation, Workforce Pressures, and the Economics of Robotics Adoption

Reimbursement, Policy & Market Access:

• Reimbursement Realities: Policy Shifts, Payment Models, and Paths to Market
• How Washington Policy and Coverage Decisions are Currently Shaping Innovation
• Creative Reimbursement Strategies Beyond Traditional Pathways
• Aligning Product Strategy with Reimbursement Readiness Early